U.S. Food and Drug Administration Center for Drug Evaluation and ResearchSkip navigation

CDER - Center for Drug Evaluation and Research Logo

Center for Drug Evaluation and Research

CDER Home Site Information Comments and Feedback What's New CDER Navigation Bar

CDER ArchivesSpecific AudiencesCDER CalendarRegulatory InformationDrug InformationAbout CDERSide Navigational Buttons

 

CDER News Along the Pike
Special Edition
Jim Morrison's Ombudsman's Corners
April 1996 to January 2003


Volume 8, Issue 6
Center for Drug Evaluation and Research

PDF version for printouts.


Introduction

This special edition of News Along the Pike contains all the essays written by Jim Morrison, the ombudsman for the Center for Drug Evaluation and Research from 1995 to 2003.

Jim began his career as a chemist with FDA in 1965 at the Los Angeles office. In 1972, he moved to the Office of Compliance in FDA's Bureau of Drugs, the forerunner to CDER. He became chief of the Over-the-Counter Compliance Branch in 1974 and special assistant to the bureau director in 1976.

In 1982, he was named director of the Regulatory Affairs Staff. A year later, he became deputy director for the Office of Drug Standards at the then National Center for Drugs and Biologics. In 1991, he became acting director of the Office of Drug Standards in CDER. He became deputy director for administration in the Office of Drug Evaluation I in 1994. He was named CDER ombudsman and senior advisor to the center director in 1995.

His thoughtful and provocative Ombudsman's Corner has served as a guiding light to the Center during an extraordinary period in the evolution of drug regulation in the United States. We are pleased to present this collection of essays as an educational service for all who work for or do business with the Center.


Contents

1996

1997

1998

1999

2000

2001

2002

2003


News Along the Pike
CDER Office of Training and Communications (HFD-210)
Parklawn Building, Room 12B-31

Editor: Norman "Joe" Oliver


totop.gif (1525 bytes)Back to Top   BackBack to Pike Index

FDA/Center for Drug Evaluation and Research
Last Updated: January 19, 2006
Originator: OTCOM/DPA
HTML by NJO